Takeo Yoshihara

Lysophosphatidylserines derived from microbiota in Crohn’s disease elicit pathological Th1 response

Yuriko Otake, Hisako Kayama, Toshihiro Kishikawa et al. · The Journal of Experimental Medicine · 2022 · 38 citations · Full text

Novel mass spectrometry‐based comprehensive lipidomic analysis of plasma from patients with inflammatory bowel disease

Shuko Iwatani, Hideki Iijima, Yuriko Otake et al. · Journal of Gastroenterology and Hepatology · 2020 · 35 citations

Tissue Drug Concentrations of Anti-tumor Necrosis Factor Agents Are Associated with the Long-term Outcome of Patients with Crohnʼs Disease

Takeo Yoshihara, Shinichiro Shinzaki, Shoichiro Kawai et al. · Inflammatory Bowel Diseases · 2017 · 23 citations

A novel artificial intelligence-based endoscopic ultrasonography diagnostic system for diagnosing the invasion depth of early gastric cancer

Ryotaro Uema, Yoshito Hayashi, Takashi Kizu et al. · Journal of Gastroenterology · 2024 · 21 citations · Full text

Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease

Takahiro Amano, Shinichiro Shinzaki, Akiko Asakura et al. · Scientific Reports · 2022 · 17 citations · Full text